These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17489723)

  • 61. Drug safety evaluation of ziprasidone.
    Citrome L
    Expert Opin Drug Saf; 2011 May; 10(3):437-48. PubMed ID: 21332416
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
    Sanaei-Zadeh H
    Am J Emerg Med; 2012 May; 30(4):627. PubMed ID: 22306388
    [No Abstract]   [Full Text] [Related]  

  • 64. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 65. US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.
    Chan VC; La Grenade L; Diak IL; Levin RL
    J Clin Psychiatry; 2015 Sep; 76(9):e1138-9. PubMed ID: 26455682
    [No Abstract]   [Full Text] [Related]  

  • 66. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
    Kinzie E; Meltzer-Brody S
    Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
    [No Abstract]   [Full Text] [Related]  

  • 67. Euprolactinemic galactorrhea secondary to domperidone treatment.
    Demir AM; Kuloglu Z; Berberoglu M; Kansu A
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):955-6. PubMed ID: 25781524
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of hyperprolactinemia during development in children and adolescents.
    Correll CU
    J Clin Psychiatry; 2008 Aug; 69(8):e24. PubMed ID: 18816151
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hyperprolactinemia with galactorrhea induced by lansoprazole: A case report].
    Duwicquet F; Gras-Champel V; Masmoudi K
    Therapie; 2017 Dec; 72(6):691-693. PubMed ID: 29061292
    [No Abstract]   [Full Text] [Related]  

  • 70. Introduction. Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics.
    Tandon R
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):1S-3S. PubMed ID: 10771447
    [No Abstract]   [Full Text] [Related]  

  • 71. Letter: Galactorrhea and antipsychotic agents.
    Masco HL
    JAMA; 1975 Dec; 234(9):913. PubMed ID: 241870
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: Galactorrhea and antipsychotic agents.
    Ament A
    JAMA; 1976 Mar; 235(11):1107. PubMed ID: 2788
    [No Abstract]   [Full Text] [Related]  

  • 73. Gingival pain: an unusual side effect of ziprasidone.
    Raghunath A
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23283612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperprolactinemia, galactorrhea, and atenolol.
    Lee ST
    Ann Intern Med; 1992 Mar; 116(6):522. PubMed ID: 1739249
    [No Abstract]   [Full Text] [Related]  

  • 75. A case of paroxetine-induced galactorrhea.
    Davenport E; Velamoor R
    Can J Psychiatry; 2002 Nov; 47(9):890-1. PubMed ID: 12500767
    [No Abstract]   [Full Text] [Related]  

  • 76. Domperidone induced galactorrhea: an unusual presentation of a common drug.
    Poovathingal MA; Bhat R; Ramamoorthi
    Indian J Pharmacol; 2013; 45(3):307-8. PubMed ID: 23833383
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Galactorrhoea and hyperprolactinemia associated with HIV postexposure chemoprophylaxis.
    Luzzati R; Crosato IM; Mascioli M; Valencich A; Giacomazzi D
    AIDS; 2002 Jun; 16(9):1306-7. PubMed ID: 12045505
    [No Abstract]   [Full Text] [Related]  

  • 78. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
    Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hyperprolactinemia and galactorrhea with duloxetine in neuropathic pain management.
    Derle E; Can U
    Agri; 2021 Oct; 33(4):268-271. PubMed ID: 34671951
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A nearly overlooked mild case of ziprasidone-induced lingual dystonia.
    Tsai AC
    J Clin Psychopharmacol; 2010 Apr; 30(2):216-7. PubMed ID: 20520306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.